MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 113 filers reported holding MERUS N V in Q3 2023. The put-call ratio across all filers is 2.34 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,141,970 | -50.3% | 430,109 | -44.5% | 9.19% | -18.7% |
| Q2 2023 | $20,408,620 | -9.5% | 775,109 | -36.7% | 11.31% | +21.1% |
| Q1 2023 | $22,542,006 | +1.7% | 1,225,109 | -14.5% | 9.34% | +12.3% |
| Q4 2022 | $22,154,726 | -26.6% | 1,432,109 | -5.0% | 8.32% | -23.5% |
| Q3 2022 | $30,187,000 | -9.7% | 1,507,109 | +2.0% | 10.88% | -4.7% |
| Q2 2022 | $33,442,000 | +0.3% | 1,477,109 | +17.1% | 11.41% | +132.8% |
| Q1 2022 | $33,355,000 | +17.0% | 1,261,534 | +40.7% | 4.90% | +51.6% |
| Q4 2021 | $28,509,000 | +205.9% | 896,502 | +16.4% | 3.23% | -11.0% |
| Q1 2020 | $9,319,000 | -36.3% | 770,183 | -25.9% | 3.63% | -33.9% |
| Q4 2019 | $14,626,000 | -21.0% | 1,038,746 | 0.0% | 5.49% | -57.9% |
| Q3 2019 | $18,510,000 | -9.2% | 1,038,746 | -25.4% | 13.04% | +84.2% |
| Q2 2019 | $20,385,000 | -7.5% | 1,391,497 | -6.7% | 7.08% | -27.4% |
| Q1 2019 | $22,029,000 | +6.3% | 1,491,497 | +0.7% | 9.75% | -2.8% |
| Q4 2018 | $20,732,000 | – | 1,480,855 | – | 10.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |